The interactions between stromal cells and tumor cells activate various molecular signaling pathways, such as interleukin-6/STAT-3/c-Myc pathway [29], and TGF-β pathway in prostate cancer [30], lung cancer [31], and colorectal cancer [32]. Here, STAT3 is linked to prostate carcinoma.